How to treat diabetes in China Shao-Liang Chen, MD, FSCAI, FACC - - PowerPoint PPT Presentation

how to treat diabetes in china
SMART_READER_LITE
LIVE PREVIEW

How to treat diabetes in China Shao-Liang Chen, MD, FSCAI, FACC - - PowerPoint PPT Presentation

How to treat diabetes in China Shao-Liang Chen, MD, FSCAI, FACC Nanjing First Hospital Nanjing Medical University, China E-mail: chmengx@126.com Current status of Diabetes in China Year Country 2000 2030 Ranking People with


slide-1
SLIDE 1

How to treat diabetes in China

Shao-Liang Chen, MD, FSCAI, FACC Nanjing First Hospital Nanjing Medical University, China E-mail: chmengx@126.com

slide-2
SLIDE 2

Current status of Diabetes in China

Year Ranking Country 2000 2030 People with diabetes(millions) 1 India 31.7 79.4 150% +150% 2 China 20.8 42.3 103% +103% 3 US 17.7 30.3 +71%

slide-3
SLIDE 3

Case presentation : clinical features

ß 71 yr., gentleman ß Unstable angina(CCAS IV), 3 weeks ß Risk factors: EH, DM, e-GFR 31% ß Resting EKG: ST-avR elevation, ST-V2-6

depression

ß Cardiac echo: LVDd 58mm, EF 42% ß Respiratory function: FEV1 32 ß Repeat ischemic stroke within 3 months

slide-4
SLIDE 4

Medication

ß Insulin, 48 U/d x 2 yeas ß Metropronol: 47.5mg/d ß ACEI(Valsartan): 10mg/d ß Atovarstatin: 20mg/d ß Nitroglycerin(long-lasting): 50mg/d ß Aspirin: 100mg/d ß Plavix: 75mg/d

slide-5
SLIDE 5

laboratory tests at admission

ß For DM,

* fasting blood glucose: 7.3~8.1mmol/L * 2hr. blood glucose: 13.7~16.5mmol/L * hb1C: 7.2

ß HDL 73.6 mg/dl ß LDL 365.44 mg/dl ß CRP-hs 2.78 mg/dl ß Serum Cr. 212 mg/dl

slide-6
SLIDE 6

Non-invasive diagnosis

ß Electron computational tomography

  • -extensive reversible myocardial

ischemia(anterior, inferior, septal, posterior wall)

ß Dual-source CTA

  • -- diffuse disease at RCA
  • -- possible LMTd bifurcation lesions
slide-7
SLIDE 7

Baseline Angiogram

AP+Caudal Ap+Cranial

slide-8
SLIDE 8

RAO+Caudal Spider view LAO for RCA

slide-9
SLIDE 9
slide-10
SLIDE 10

SYNTAX score

ß Final score: 67 scores ß Question 1:

favors CABG?

slide-11
SLIDE 11

Reluctance from surgeon

ß Renal dysfunction ß Reduced respiratory function ß Diffuse RCA lesions ß Question 2:

Hybrid Procedure? Refused by patient PCI

slide-12
SLIDE 12

Question 3: strategy?

ß First RCA or LAD+LCX? ß Stenting technique for LAD+LCX?

slide-13
SLIDE 13

Stenting LM –culotte stenting

Sequential pre-dilation for LCX

slide-14
SLIDE 14

After stenting LCX- ostial LM with 3.0x23mm SES, And post-dilation with 3.5x12 NC Sprinter Re-wiring and dilating from ostial LAD

slide-15
SLIDE 15

After first kissing Stenting LAD-LM with 3.5x28 SES After stenting and post-dilation with 4.0 x8 balloon

slide-16
SLIDE 16

Re-wiring LCX Scond kissing After stenting procedure

slide-17
SLIDE 17

Stenting RCA

Sequential inflation After 3 stents

slide-18
SLIDE 18

Fourth stent inflated Final results of stenting RCA

slide-19
SLIDE 19

Adjunctive medication

ß Rusuvastatin: 20mg/d ß Eizomaibu: 10mg/d ß ASA 100mg/d ß Plavix: 75m/d ß Anti-hypertension therapy ( 3 regimes) ß LDL at target level: 82mg/dl ß CRP-hs: 1.2mg/dl ß eGRF: 38%

slide-20
SLIDE 20

Angiogram at-8 month: LMTd

slide-21
SLIDE 21

Angiogram at 8-month: RCA

Question 4: How to ?

slide-22
SLIDE 22

Cutting ballooning RCA

Multiple-cutting ballooning

slide-23
SLIDE 23

2-year post-first PCI procedure

slide-24
SLIDE 24

Question 5: Next strategy? CABG?

slide-25
SLIDE 25

Take home messages

ß Diabetes is an independent factor of ISR ß Role of SYNTAX score in this patient ß Multiple-risk factors predicts the worse

  • utcome

ß Maximal medication would be of great value

in improving clinical outcomes------ CABG still is the golden care for diabetic patients

slide-26
SLIDE 26

Thanks for your attention!